Envision Healthcare Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Oil rises on Iran war stalemate; near-term potential for further gains seen limited
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Envision Healthcare (EVHC) Misses Q2 EPS by 2c, FY EPS Guidance Comes in Light
August 3, 2016 4:56 PM EDTEnvision Healthcare (NYSE: EVHC) reported Q2 EPS of $0.34, $0.02 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $1.64 billion versus the consensus estimate of $1.66 billion.
GUIDANCE:
Envision Healthcare sees FY2016 EPS of $1.42-$1.47, versus the consensus of $1.49.
... More